UltraSight™ Partners with Jefferson Health

UltraSight™ Partners with Jefferson Health to Expand Access to Cardiac Imaging Through its Echo Stewardship Platform

Supported by the Israel Innovation Authority, the study aims to speed right-ventricular assessment in suspected pulmonary embolism

TEL AVIV, ISRAEL AND PHILADELPHIA , PA, UNITED STATES, January 7, 2026 / UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced a partnership with Jefferson Health, one of the largest academic health systems in the United States, in a clinical study to advance rapid incorporation of diagnostic-quality FoCUS echocardiogram workflows. The pilot is funded in part by the Israel Innovation Authority (IIA) through the Jefferson–Israel 2025 Health Tech Pilot Program, which provides Israeli companies with real-world clinical environments to evaluate new technologies, accelerate validation, and support successful entry into the U.S. healthcare market. The Jefferson Health/UltraSight™ pilot will evaluate how advanced practice providers use UltraSight’s Echo Stewardship Platform to acquire diagnostic-quality echocardiographic views at the bedside.